Insider · CIK 0001774807

Todisco Joseph

Reports to the SEC for 3 companies · SAN MATEO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001774807

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-22	TLPHTALPHERA, INC.A Award	Director	AAward	+5,100 sh	—	—	11,497
2026-06-22	TLPHTALPHERA, INC. · Director Stock Option (right to buy)A Award	Director	AAward	+30.7K sh	—	—	30,700
2026-02-04	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+77.2K sh	—	—	774,749
2026-01-23	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+226K sh	—	—	724,899
2026-01-23	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−27.3K sh	$7.27	−$199K	697,593
2026-01-17	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−22.7K sh	$6.78	−$154K	498,999
2026-01-16	CRMDCorMedix Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+29.6K sh	$3.38	+$100K	521,664
2026-01-16	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−29.6K sh	—	—	411,245
2026-01-12	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.4K sh	$7.15	−$125K	492,079
2025-12-18	CRMDCorMedix Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+30K sh	$4.43	+$133K	539,496
2025-12-18	CRMDCorMedix Inc.S Sale	Director, Chief Executive Officer	SSale	−30K sh	$12.00	−$360K	509,496
2025-12-18	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−30K sh	—	—	370,000
2025-10-15	TLPHTALPHERA, INC.A Award	Director	AAward	+6,397 sh	—	—	6,397
2025-10-15	TLPHTALPHERA, INC. · Director Stock Option (right to buy)A Award	Director	AAward	+38.4K sh	—	—	38,381
2025-09-12	CRMDCorMedix Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	$3.47	+$174K	559,496
2025-09-12	CRMDCorMedix Inc.S Sale	Director, Chief Executive Officer	SSale	−50K sh	$13.00	−$650K	509,496
2025-09-12	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	216,667
2025-05-10	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−21.2K sh	$11.66	−$247K	509,496
2025-04-01	CRMDCorMedix Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+59.2K sh	$3.38	+$200K	530,721
2025-04-01	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−59.2K sh	—	—	440,830
2025-01-17	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+188K sh	—	—	495,528
2025-01-17	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−24K sh	$12.17	−$292K	471,551
2025-01-10	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.8K sh	$11.19	−$200K	308,028
2024-05-10	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−27K sh	$5.17	−$139K	325,857
2024-03-13	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+13.6K sh	$3.74	+$50.7K	352,839
2024-01-12	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+133K sh	—	—	353,059
2024-01-12	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−13.8K sh	$3.47	−$47.8K	339,278
2024-01-12	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+267K sh	—	—	266,667
2023-09-08	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$3.71	+$37.1K	219,726
2023-05-17	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$4.58	+$22.9K	209,726
2023-05-17	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+5,000 sh	$4.58	+$22.9K	209,726
2023-05-10	CRMDCorMedix Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−37.4K sh	$5.30	−$198K	204,726
2023-01-14	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2022-11-15	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$3.82	+$76.4K	242,169
2022-08-24	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,700 sh	$3.92	+$18.4K	222,169
2022-05-16	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$3.38	+$33.8K	217,469
2022-05-10	CRMDCorMedix Inc.A Award	Director, Chief Executive Officer	AAward	+207K sh	—	—	207,469
2022-05-10	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000
2022-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+4,442 sh	—	—	328,756
2022-05-07	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−1,562 sh	$3.40	−$5,310.8	327,194
2022-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−4,442 sh	—	—	0
2022-03-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Executive Vice President	AAward	+145K sh	—	—	144,928
2022-03-03	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	Executive Vice President	AAward	+290K sh	—	—	289,856
2022-03-01	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+11.1K sh	—	—	311,007
2022-03-01	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−3,906 sh	$4.45	−$17.4K	307,101
2022-03-01	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+26.5K sh	—	—	333,645
2022-03-01	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	Executive Vice President	FTax Payment	−9,331 sh	$4.45	−$41.5K	324,314
2022-03-01	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−11.1K sh	—	—	11,111
2022-03-01	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Executive Vice President	MExercise/Conversion	−26.5K sh	—	—	79,634
2022-02-27	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Executive Vice President	MExercise/Conversion	+29.7K sh	—	—	311,003

Recent filings

Accepted (ET)
Jun 244
Todisco Joseph0001774807-26-000005
SEC(opens sec.gov)
Feb 64
Todisco Joseph0001213900-26-013406
SEC(opens sec.gov)
Jan 274
Todisco Joseph0001213900-26-008478
SEC(opens sec.gov)
Jan 204
Todisco Joseph0001213900-26-005425
SEC(opens sec.gov)
Dec 194
Todisco Joseph0001213900-25-124063
SEC(opens sec.gov)
Oct 164
Todisco Joseph0001774807-25-000005
SEC(opens sec.gov)
Sep 124
Todisco Joseph0001213900-25-087374
SEC(opens sec.gov)
Sep 124
Todisco Joseph0001213900-25-087371
SEC(opens sec.gov)
Apr 24
Todisco Joseph0001213900-25-027598
SEC(opens sec.gov)

Companies

Address

C/O TALPHERA, INC. 1850 GATEWAY, SUITE 175

SAN MATEO, CA, 94404